Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type

Type

Guidance programme

Advice programme

Showing 1 to 10 of 2549

TitleReference numberPublishedLast updated
Belantamab mafodotin with bortezomib and dexamethasone for previously treated multiple myelomaTA1149
Acne vulgaris: managementNG198
Digital technologies for managing non-specific low back pain: early value assessmentHTG712
Vorasidenib for treating astrocytoma or oligodendroglioma with IDH1 or IDH2 mutations after surgery in people 12 years and overTA1147
Sodium zirconium cyclosilicate for treating hyperkalaemiaTA1148
Ripretinib for treating advanced gastrointestinal stromal tumours after 3 or more kinase inhibitorsTA1146
Pembrolizumab for neoadjuvant and adjuvant treatment of resectable locally advanced head and neck squamous cell carcinomaTA1145
Suspected cancer: recognition and referralNG12
Menopause: identification and managementNG23
Ovarian cancerQS18

Results per page

  1. 10
  2. 25
  3. 50
  4. All